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Background: Preterm birth confers a high risk of adverse long term health outcomes for survivors, yet the underlying
molecular mechanisms are unclear. We hypothesized that effects of preterm birth can be mediated through measurable
epigenomic changes throughout development. We therefore used a longitudinal birth cohort to measure the epigenetic
mark of DNA methylation at birth and 18 years comparing survivors of extremely preterm birth with infants born at term.
Methods: Using 12 extreme preterm birth cases and 12 matched, term controls, we extracted DNA from archived
neonatal blood spots and blood collected in a similar way at 18 years of age. DNA methylation was measured at
347,789 autosomal locations throughout the genome using Infinium HM450 arrays. Representative methylation
differences were confirmed by Sequenom MassArray EpiTYPER.
Results: At birth we found 1,555 sites with significant differences in methylation between term and preterm
babies. At 18 years of age, these differences had largely resolved, suggesting that DNA methylation differences at
birth are mainly driven by factors relating to gestational age, such as cell composition and/or maturity. Using
matched longitudinal samples, we found evidence for an epigenetic legacy associated with preterm birth,
identifying persistent methylation differences at ten genomic loci. Longitudinal comparisons of DNA methylation
at birth and 18 years uncovered a significant overlap between sites that were differentially-methylated at birth and
those that changed with age. However, we note that overlapping sites may either differ in the same (300/1,555) or
opposite (431/1,555) direction during gestation and aging respectively.
Conclusions: We present evidence for widespread methylation differences between extreme preterm and term
infants at birth that are largely resolved by 18 years of age. These results are consistent with methylation changes
associated with blood cell development, cellular composition, immune induction and age at these time points.
Finally, we identified ten probes significantly associated with preterm individuals and with greater than 5%
methylation discordance at birth and 18 years that may reflect a long term epigenetic legacy of preterm birth.Background
Preterm birth, defined as birth earlier than 37 weeks of
gestation, is a major cause of neonatal death. Moreover,
preterm birth imposes substantial health burdens on
survivors; for example, children born preterm are four to
five times more likely to develop brain and cardiovascular* Correspondence: jeff.craig@mcri.edu.au
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distribution, and reproduction in any mediumdisorders compared with infants born at term [1,2]. As a
group, preterm survivors are at increased risk for chronic
illnesses later in life relating to respiratory [3,4], visual
[5], cardiovascular [6], hearing [7,8] and intellectual/
behavioral [9,10] impairment. The molecular mechanisms
that might confer increased risk on these complex traits
are incompletely understood.
Preterm birth imposes stress on infants due to premature
removal from the intrauterine environment. Environmental
factors relevant to preterm birth, such as nutrition,
temperature change, toxins, and hypoxia/hyperoxia (that
is, stressors) can alter gene expression in the short and/orntral Ltd. This is an open access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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in utero [13-15], or maternal care during post-natal
development [16-18] are associated with stable epigenetic
alterations in the offspring (such as DNA methylation and
histone post-translational modifications) accompanied by
metabolic or behavioral alterations. Other studies have
shown that long-term effects of gestational hypoxia in a
mouse model may be independent of lasting epigenetic
alterations, but dependent on gene-environment inter-
actions [19]. These persistent, environmentally induced
phenotypic alterations have been attributed to aberrant
organ development following transiently disrupted cell
signaling [19]. Thus, mechanisms mediating long-term
phenotypic variation in response to early environment
remain controversial.
Genomic regions subject to DNA methylation change
have been identified during gestation [20-22], neonatal
development [23] and the entire lifespan [24-28]. The aim
of this exploratory study was to assess genome-wide DNA
methylation profiles of extremely preterm survivors com-
pared with term controls at both birth and at 18 years of
age, using a longitudinal case-control study design.
Methods
Ethics approval
The study was approved by the Human Research Ethics
Committees of the Royal Women’s Hospital and the Royal
Children’s Hospital (Melbourne) and conformed to the
Helsinki Declaration.
Subjects
The subjects of this study were 12 preterm infants born at
less than 31 weeks of gestational age and 12 term controls.
All were born at the Royal Women’s Hospital, Melbourne
in 1991 or 1992, and enrolled in a longitudinal study from
birth. They were derived from a list of 18 pairs of subjects
who consented (parents and subjects) to participate in
the study and provide neonatal Guthrie cards (GCs) and
18-year dried blood spots. Subjects were matched for
sex, ethnicity (all Caucasian), and singleton birth status.
Gestational age (GA), sex, and delivery modes of subjects
are shown in Table 1.Table 1 Demographic, clinical and sample characteristics





Gestational age, weeksa 26 (25 to 30) 39 (36 to 42)
Age at Guthrie card birth sample, daysa 6.5 (5 to 20) 4.0 (4 to 5)
Sex, maleb 8/12 (67%) 9/12 (75%)
Born by Cesarean sectionb 3/12 (25%) 8/12 (33%)
Mother experienced laborb 9/12 (75%) 10/12 (83%)
aMedian (range).
bNumber/total number (%).DNA extraction and bisulfite conversion from dried
blood spots
Six to ten 3 mm punches taken from dried blood spots
were placed in a 1.5 ml tube with 100 μl water with a
single tungsten carbide bead (3 mm; catalog number
69997; Qiagen, Victoria, Australia). Samples were macer-
ated with a TissueLyser II (Qiagen) (time: 5 × 30 seconds,
frequency: 30 Hz). Beads were removed, and samples were
further processed using the QIAamp DNA Mini Kit
(Qiagen), in accordance with the manufacturer’s instruc-
tions, but with the following modifications. The macerated
sample was incubated with 190 μl of extraction buffer
(ATL; SDS-containing proprietary formula extraction
buffer; Qiagen) for 10 minutes at 85°C for 10 minutes.
Supernatant was collected and the ATL extraction of the
homogenate was repeated twice. The resulting extract was
pooled and further processed by proteinase K digestion
(60 μl; 10 mg/ml at 56°C for 1 hour), then incubated with
600 μl buffer AL for 10 minutes at 70°C, followed by
addition of 600 μl 100% ethanol. After mixing by inver-
sion, samples were loaded onto a single QIAamp column
by repeat centrifugation. Following washing, DNA was
collected by incubating twice with 100 μl buffer AE
(10 mM Tris-HCl, 0.5 mM EDTA, pH 9.0) for 10 minutes,
and once with 50 μl buffer AE for 10 minutes. The com-
bined eluates were placed in a Speedvac at 45°C for
8 hours. The dry pellet was resuspended in 40 μl TE
(10 mM Tris-HCl, 1 mM EDTA, pH 8.0) and quantified
by spectrophotometry (Nanodrop, Wilmington, DE, USA)
yielding a median of 1.7 μg DNA. Residual homogenates
from a subset of samples were subjected to the same
extraction process twice, yielding an additional 1.6 μg
DNA. DNA samples (1 μg) were bisulfite-converted using
the MethylEasy Xceed bisulphite conversion kit (Human
Genetic Signatures, North Ryde, Australia), in accordance
with the manufacturer’s instructions. Conversion efficiency
was confirmed by bisulfite-specific PCR [29].Infinium methylation analysis
We used the Illumina Infinium HumanMethylation 450
(HM450) BeadChip platform, which interrogates more
than 485,000 CpG dinucleotides, with probes targeted to
CpG islands (CGIs), and their adjacent shores (2 kb regions
flanking CGIs) and shelves (2 kb regions flanking shores);
non-coding RNA; gene promoters, enhancers, and inter-
genic regions; and regions associated with epigenetic repro-
gramming of fibroblasts to inducible pluripotent stem cells
(reprogramming-specific differentially methylated region;
rDMR) [30,31]. Bisulfite treated DNA was hybridized to
HM450 BeadArrays, with both birth and 18-year samples
from three preterm and three term probands (total of
twelve samples) selected per array in a scrambled order by
ServiceXS (Amsterdam, The Netherlands).
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environment (version 2.14.1) [32] using the minfi package
[33]. Data quality was assessed with plots derived from
various control probes on the array. Probes from the X and
Y chromosomes (n = 11,648) were removed. Probes were
excluded if they failed in one or more samples based on a
detection P-value of greater than 0.01 (n = 96,632). This
method will remove any probes that might correspond
to degraded regions of the genome from long-term stor-
age of the samples at room temperature. One term birth
sample with mean detection P > 0.05 was excluded from
analysis. The data were pre-processed using the Illumina
method (bg.correct = ‘FALSE’, normalize = ‘controls’) and
subset-quantile within-array normalization (SWAN) was
performed [34]. Probes targeting CpG dinucleotides con-
taining a known single nucleotide polymorphism (SNP)
and HM450 control probes were excluded from analyses
(n = 23,365). The resulting dataset comprised 347,789
autosomal probes from 11 term and 12 preterm birth
samples, and 12 term and preterm 18-year samples. The
log2 ratio of methylated probe intensity to unmethylated
probe intensity was calculated in minfi, denoted as M-
values used for statistical analyses, and converted to β
values ranging from 0 to 1 (0 to 100% methylation) [35,36].
The HM450 data are available from Gene Expression
Omnibus (GEO) with an accession number of GSE51180.
Statistical analysis
The data underwent unsupervised hierarchical clustering
analysis and multi-dimensional scaling (MDS) using lumi
[35]. Heatmaps and dendrograms were drawn with gplots
[37]. Differential methylation analysis was performed on
M-values using the limma package [38] setting the false
discovery rate (FDR) cut-off point at less than 0.05 using
the Benjamini-Hochberg procedure [39]. Correlation of
methylation values at birth and 18 years across individuals
was assessed using the duplicateCorrelation function [40].
For differential analysis, a linear model was fitted with age,
case-control status (preterm or term), and predictive
factors correcting for sex and array effects. Differentially
methylated genes were determined if any probe associated
with the gene was called ‘differentially methylated’. Gene
ontology enrichment was performed using the DAVID
bioinformatics tool under the default settings [41,42] and
pathway analysis using Ingenuity Pathways Analysis (IPA)
software (Ingenuity Systems, Redwood City, CA, USA).
Differentially methylated probes (DMPs) were classified as
gene-related, CGI-related [43], DMRs [44], or regulatory
regions (promoters, enhancers, and DNAse hypersensitivity
sites). Enrichment and gene set tests were populated with
probe IDs using annotations provided in the Illumina
HM450 manifest (version 1.2). Gene lists were consolidated
by replacing multiple isoforms (for example, Protocadherin
genes) with a single RefSeq entry, or including multipleRefSeq entries associated with a single probe where bidir-
ectional gene loci (for example, ABI3 and GNGT2) or host
gene/non-coding RNA genes (for example, ITPR1 and
EGOT) were identified. The limma function decideTests
was used to identify directional correlations (method = ‘sep-
arate’; adjustment method = ‘BH’; and P = 0.05) and visual-
ized with heatDiagram. Genomic location enrichment was
determined by calculating the ratios of observed/expected
(O/E) probes in each category, and classified as over-
represented (O/E ratio >1) or under-represented (O/E
ratio <1), with significance assigned using hypergeometric
means tests (statistics package: phyper function, one-sided
lower tail for under-representation or one-sided upper tail
for over-representation). Significance of birth/DMP and
age/DMP overlap was assessed using Fisher’s exact test for
count data (statistics package: fisher.test).
Sequenom MassArray target validation
Target validation was performed using the Sequenom
MassArray EpiTYPER (Sequenom, San Diego, USA),
performed as previously described [21,29]. Amplicons were
designed using the Sequenom EpiDesigner [45] and
MassArray [46], and tested in silico using methBlast [47]
software. Oligonucleotide sequences were prepared
(see Additional file 1: Table S1) such that forward primer
sequences contain a 10 bp tag (AGGAAGAGAG) at their
5′ ends, and reverse primer sequences contain a 31 bp
tag (CAGTAATACGACTCACTATAGGGAGAAGGCT)
at their 5′ ends. Amplification was performed using 1 μl
bisulfite-converted DNA with the FastStart kit (Roche,
Mannheim, Germany) in 15 μl reactions with thermocy-
cling conditions as follows: 94°C for 2 minutes; 5 cycles of
94°C for 30 seconds, 60°C for 30 seconds, and 72°C for
30 seconds; 35 cycles of 94°C for 30 seconds, 62°C for
30 seconds, and 72°C for 30 seconds; and final elongation
at 72°C for 6 minutes. Data processing was carried out in
triplicate using the median methylation level at specific
CpG sites. Raw data obtained from MassArray EpiTYP-
ING were cleaned systematically using an R-script to re-
move samples that failed to generate data for more than
70% of the CpG sites tested. In addition, technical repli-
cates showing 10% or greater absolute difference from the
median value were removed, and only samples with at
least two successful technical replicates were analyzed.
Results
An improved method of DNA extraction from
Guthrie cards
We used a bead-facilitated maceration method involving
repeat extractions, tested for applicability for Infinium
HM450 arrays [48]. DNA from archived GCs sampled at
birth and at 18 years of age yielded a median of 1.6 μg
DNA after the first extraction, increasing to 3.3 μg DNA
after two additional rounds of extraction using six to ten
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ered than previously reported [49-52], and were similar
using blood spots stored desiccated at room temperature
for 1 or 18 years (data not shown).
Exploratory analysis of components of
epigenetic variation
The characteristics of our study cohort and sample collec-
tion are summarized in Table 1. MDS identified age (birth
versus 18 years) as the predominant source of variation
within the dataset (see Additional file 2: Figure S1). We
noted increased inter-individual variability between birth
samples held in long-term storage (see Additional file 2:
Figure S1; also data not shown). However, the similarity
of β-value distributions of birth and 18-year samples
(see Additional file 2: Figure S2) and the probe intensity
of control probes (data not shown) indicated similar
performance of these samples on the HM450 platform.
To explore other components of variation, we tested asso-
ciations of sex, delivery mode (spontaneous or iatrogenic;
vaginal or lower uterine cesarean section; and labor or
induced) and array. Sex and array were identified as
significant factors, and were used as explanatory variables
in linear models for subsequent analyses. Probes associ-
ated with sex included several autosomal loci homologous
to X or Y chromosomes (data not shown), probably
reflecting cross-hybridization, as previously reported [53].
Identification of gestational age-associated differential
methylation at birth
We tested for differential methylation between preterm
and term birth samples and identified 1,555 DMPs (birth
DMPs; FDR < 0.05) (Figure 1A,B; see Additional file 3:
Table S2). Cross-platform validation was performed using
Sequenom EipiTYPER assays targeting CpG sites near
DMPs, because the methylation profiles of CpG sites in
close proximity are highly correlated [54]. Specifically,
we tested DNA methylation within the first intron of the
VWF gene as a representative enhancer site birth DMP,
which is known to regulate gene expression [55] (two
probes, Pearson r2 = 1.000, P < 0.012; r2 = 0.954, P = 0.023
across all samples) (see Additional file 2: Figure S3). In
agreement with two previous studies of DNA methylation
associated with GA, we observed birth DMPs at gene loci
encoding the transcription factor nuclear factor I/X
(NFIX, [20]), oxytocin (OXT), and arginine vasopressin
(AVP) [22].
Gene ontology classes associated with birth DMPs
showed a bias towards biological processes involved in
GTPase signaling (for example, PLEKHG5, RASA3, and
AGAP1), transcription (for example, LEF1, DNMT3A, and
NCOR2), embryonic morphogenesis for example, WNT3A,
NODAL, and SHANK3), cell growth and proliferation
(for example, RUNX1, BMP1, and DOT1L), and nervoussystem (for example, FGF1, GABBR1, and GDNF) and
hematological (for example, AIRE, IL12A, and PBX1)
development (see Additional file 4: Table S3; DAVID
ontology). Pathway analysis showed over-representation
of antigen presentation pathway genes (see Additional
file 4: Table S3; IPA ‘Pathway’). Analysis of upstream
regulators of genes associated with birth DMPs found a
significant overlap with genes regulated by the transcrip-
tion factor CREB1 and the Ca2+/calmodulin-dependent
protein kinase complex, CaMKII (P < 10-4) (see Additional
file 4: Table S3; IPA ‘Upstream’).Age-related changes in DNA methylation overlap
with birth DMPs
We next sought to identify probes that differ between
whole blood from infants and 18-year-olds. We compared
all birth samples with all 18-year samples, independent
of preterm status (birth, n = 23; 18 years, n = 24). Inter-
estingly, we found no overall evidence for a correlation
within individuals between the two time points (consensus
correlation; r = −0.0343). We identified 116,603 age-associ-
ated DMPs (‘age DMPs’, adjusted P < 0.05) including 3,244
probes with mean DNA methylation (β) change greater
than 0.2 (Figure 1C,D; see Additional file 5: Table S4).
Because age DMPs clustered the birth samples according
to preterm/term status (Figure 1C), we tested the hy-
pothesis that epigenetic change is continuous from mid-
gestation to 18 years of age; that is, that birth DMPs and
age DMPs would share common probes. To account
for methylation changes occurring during gestation, we
performed analyses using birth and 18-year samples
from the term group (birth, n = 11; 18 years, n = 12) and
preterm group (birth, n = 12; 18 years, n = 12) separately.
Comparing birth DMPs with age DMPs as defined from
preterm subjects (n = 56,515 probes), we found a continuum
of change comprising 934 of 1,555 (60%; P < 2.2 × 10-16,
odds ratio (OR) = 7.76) sites of methylation difference that
were also differentially methylated in the same direction
by 18 years of age, and 34 of 1,555 (2%; P < 2.2 × 10-16,
OR = 0.11) sites that had changed in the opposite direction
by 18 years age (Figure 1E). By contrast, comparing
birth DMPs with age DMPs defined from term subjects
(n = 63,127), we identified 300 of 1,555 (19%; P < 2.2 ×
10-16, OR = 1.08) probes that were directionally corre-
lated, and 431 of 1,555 (28%; P < 2.2 × 10-16, OR = 1.73)
probes that were differentially methylated in the opposite
direction at 18 years (Figure 1F).
We further investigated the overlap of birth DMPs and
age DMPs by cluster analysis, and found that preterm birth
samples appeared as a sub-group distinct from the term
birth and 18-year samples (Figure 2A,B) using directionally
correlated probes. By contrast, using the directionally op-
posed probes, we found that term birth samples appeared
Figure 1 Preterm-associated differentially methylated probes (DMPs) at birth overlap with age-associated DMPs. (A) Multi-dimensional
scaling (MDS) and (B) heatmap plots of 1,555 significant preterm birth DMPs (comparing preterm birth samples with term birth samples). (C)
MDS and (D) heatmap plots of 3,244 combined age DMPs with β > 0.2 (comparing all birth samples with all samples obtained at 18 years). (E,F)
Heat diagrams displaying all birth DMPs (upper rows) with probes colored by the direction of methylation change from preterm to term, either
increasing (yellow shading) or decreasing (blue shading). Comparison of overlap of birth DMPs and age DMPs determined using either (E)
preterm or (F) term subjects showed a high proportion of sites that differed in a similar direction when assessing methylation changes with age
in preterm subjects (934 probes changed in the same direction; 34 probes changed in the opposite direction). By contrast, methylation changes
with age in term subjects showed more sites that differed in the opposite direction with age (300 probes changed in the same direction; 431
probes changed in the opposite direction). The sample groups are color coded as follows: term birth, blue; preterm birth, black; term birth at
18 years, green; preterm at 18 years, red.
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plots of the distribution of mean β-values (Figure 2G,H).
We found that birth DMPs and age DMPs showed simi-
lar ontology and pathway enrichments (see Additionalfile 6: Table S5). These included GTPase signaling, tran-
scription and embryonic morphogenesis, nervous system
and hematological system development, and the antigen
presentation pathway. Transcription factors were identified
A B C D
E F G H
Figure 2 Comparison of correlated and directionally opposed birth and age differentially methylated probes (DMPs). (A) Multi-dimensional
scaling (MDS) and (B) heatmap plots of 300 directionally correlated birth DMPs. Mean group β-values of correlated DMPs that (C) increased
(159 probes) or (D) decreased (141 probes) with age. (E) MDS and (F) heatmap plots of 431 directionally opposed age and birth DMPs. Mean
group β-values of directionally opposed DMPs that were (G) higher (314 probes) or (H) lower (117 probes) in term birth samples. The sample
groups are color coded as follows: term birth, blue; preterm birth, black; term birth at 18 years, green; preterm at 18 years, red. Birth DMPs and
age DMPs (defined using term group only) were analyzed by sub-setting probes that had changed in the same (correlated) or differing
directions (opposing).
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with age DMPs, with a significant overlap of genes reg-
ulated by NLRC5, NKX2-3, and FOXC1 (P < 10-4) (see
Additional file 6: Table S5). Upstream pathway analysis
of genes that showed a continuum of methylation change
from preterm birth to 18 years (directionally correlated
probes) showed enrichment for genes regulated by the
transcription factors NLRC5, CIITA, and PML (P < 10-4)
(see Additional file 7: Table S6), whereas genes that
showed methylation change in the opposing direction were
over-represented by genes regulated by the transcription
factors MTA1, JUN, and TP53 (P < 10-4) (see Additional
file 8: Table S7).
To determine whether age DMPs and birth DMPs were
enriched at similar genomic regions (for example, gene-
associated regions, regions with proximity to CGI) or
regulatory functions (for example, promoters, enhancers),
we performed an enrichment analysis of birth DMPs with
contextual data supplied with the HM450 arrays. Birth
DMPs and age DMPs also showed similar genomic context
biases (Figure 3A). We found that promoters (birth DMPs:
0.4-fold, P = 5.8 × 1041; age DMPs: 0.4-fold, P = 1.7 × 10-75)
and CGIs (birth DMPs: 0.5-fold, P = 5.0 × 10-55; age DMPs:0.5-fold, P = 1.2 × 10-97) were both under-represented.
By contrast, enhancers were over-represented (birth DMPs:
1.7-fold, P= 5.6 × 10-37; age DMPs: 1.9-fold, P = 2.6 × 10-111),
as to a lesser extent were gene bodies (birth DMPs: 1.2-
fold, P = 1.2 × 10-6; age DMPs: 1.2-fold, P = 3.2 × 10-13).
We also tested enrichment at rDMRs, and observed sig-
nificant enrichment (birth DMPs: 2.3-fold, P = 4.0 × 10-12;
age DMPs: 3.4-fold, P = 7.0 × 10-66).
To test if such concordance was related to probe vari-
ability or potential statistical/array artifacts, we compared
genomic context enrichment with two probe sets identi-
fied using 18-year DNA methylation profiles. We used
the top 1,500 most variable methylated probes (VMPs)
across all 18-year samples and the top 1,500 probes
ranked by odds of differential methylation, comparing
18-year DMPs for both preterm and term groups. We
found that these sets of probes showed unique genomic
context distributions compared with age DMPs and
birth DMPs, suggesting a biological rather than tech-
nical basis for genomic context profiles (Figure 3A,B).
Notably, top-ranked 18-year DMPs showed the opposite
genomic context profiles compared with birth DMPs
and age DMPs.
AB
Figure 3 Genomic and sequence context of differentially methylated probes (DMPs). Enrichment or depletion of DMPs displayed as the
log10 of the observed/expected frequencies for each category with significance from hypergeometric test results displayed as *P < 10
-5, **P < 10-10,
and ***P < 10-20. (A) Genomic enrichment distribution of 1,555 birth DMPs (black) and 3,244 age DMPs (white) showed similar profiles.
(B) Top 1,500 probes ranked by odds of differential methylation at 18 years (18-year DMPs; dark grey) and the top 1,500 most variable
methylated probes (18-year VMPs; light grey) showed distinct enrichment profiles, with the 18-year DMPs showing the opposite
enrichment to the birth DMPs and age DMPs.
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Testing for differential methylation between term and
preterm individuals in 18 year samples failed to detect any
significant probes after correction for multiple testing.
To further examine the possibility of a persistent effect
of preterm birth at both time points, we compared all
preterm and term samples in the two groups (birth and
18-year samples combined for each group) and found
109 combined preterm DMPs at a genome-wide level of
significance (adjusted P < 0.05) (see Additional file 9:
Table S8). Using MDS and hierarchical clustering, we
found that this probe set separated sample groups almost
perfectly by age and preterm/term status (Figure 4A,B).
Interestingly, eight of these probes were not called as
significant using only the birth samples. Six of these
eight probes showed a mean β difference of greater than
0.1 between the preterm and term groups at both time
points, and are located at the PCSK9, TRIM71, SLC44A4,
GPC6, and NFYA gene bodies and one intergenic site.
Of the 109 combined preterm DMPs, 11 showed a mean
difference of β > 0.05 at both time points (Figure 4C,D),
including two intergenic probes targeting CpG sites270 bp apart within a CGI shore and a site within the
TINAGL1 3′ UTR. Intriguingly, the two intergenic persist-
ent sites of methylation difference flank a binding site for
the early growth response 1 (EGR1) transcription factor
identified previously in erythroid cells (see Additional
file 2: Figure S3) [56].
Sequenom EpiTYPER confirmed differential methylation
of regions flanking the EGR1-binding site (P < 0.05)
(see Additional file 2: Figure S4) and the TINAGL DMP
(P < 0.05) (see Additional file 2: Figure S5). However,
Sequenom did not detect significant differential methyla-
tion at a putative persistent DMP located at the MAP3K8
gene (see Additional file 4: Table S3). We speculate
that this may be due to the probe region containing
two annotated deletion/insertion genetic variants of un-
known allele frequency (rs67613960 and rs71525594)
that may have confounded methylation measures [53,57].
Thus, among the 109 significant combined preterm
DMPs, we found a total of 10 putative persistent preterm
DMPs, defined as sites showing mean methylation dif-
ference of β > 0.05 at both time points. Taken together,
these results raise the possibility that a minority of
A B
C D E
Figure 4 Differentially methylated probes (DMPs) associated with preterm birth identified using birth and 18-year blood spots. (A)
Multi-dimensional scaling (MDS) and (B) heatmap plots show 109 combined preterm DMPs (comparing preterm with term, combining birth and
18-year samples for both groups). (C) Scatterplot displaying mean methylation differences (δβ) of birth (x-axis) and 18-year (y-axis) samples.
Volcano plots showing δβ (x-axis) versus nominal P-values (−log10 scale) of combined preterm DMPs, with red points denoting probes with
absolute methylation difference of greater than 0.05 and nominal P < 0.01 at (D)18 years and (E) birth. The sample groups are color coded as
follows: term birth, blue; preterm birth, black; term birth at 18 years, green; preterm at 18 years, red.
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preterm birth.
Discussion
In this exploratory study, we examined DNA methylation
profiles associated with very preterm birth (<31 weeks of
gestation) using longitudinally collected blood sampled
from newborns and 18-year-olds, both stored as dried
blood spots. We identified methylation differences in birth
samples at several gene loci previously reported to co-vary
with gestational age. These results demonstrate the utility
of archived birth blood spot DNA for methylation profiling,
in accordance with other recent studies [48,49,52].
We found widespread differences in DNA methylation at
birth in preterm infants compared to with term controls.
In agreement with previous studies [23,28,58], our data
revealed methylation changes in blood associated with
age. Some of these methylation differences are likely toreflect cell composition or functional differences in blood
between preterm and term neonates, and between birth
and at 18 years of age. For example, preterm-associated
methylation differences at birth coincide with hematological
changes that are correlated with gestational age, such as
leukocyte [59,60] and nucleated reticulocyte [61] content.
Further, gestational and age-related methylation changes
may also reflect maturation of blood cells, including innate
cytokine and adaptive immune induction [62-64]. Methyla-
tion change driven by these effects is evidenced by
over-representation of birth DMPs and age DMPs in gene
networks involved in hematological system development
(see Additional file 4: Table S3; see Additional file 6: Table
S5; see Additional file 7: Table S6).
Blood cell composition is well established as a predictive
factor for inter-individual methylation variation in whole
blood [65,66]. However, this variable does not readily ex-
plain the significant overlap in differentially methylated
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http://genomemedicine.com/content/5/10/96CpGs between preterm and term subjects at birth and also
between birth and 18 years of age. We found 159 sites
that showed increased methylation and 141 that showed
decreased methylation from preterm to term birth and
subsequently up to adulthood, suggesting a continuum
of methylation change from mid-gestation to young
adulthood for some regions of the genome (Figure 2).
Genes associated with these sites were over-represented by
direct targets of the upstream transcription factors NLRC5
and CIITA, master regulators of the MHC I-dependent
[67-69] and MHC II-dependent [70,71] immune responses,
respectively. These observations are consistent with
gestational and post-natal changes to the immune system,
during which time MHC responses are initiated [72]. We
also found that genes associated with a continuum of
methylation change were over-represented in embry-
onic development/morphogenesis and nervous system
development, consistent with previous reports [73,74].
Teschendorff and co-workers have previously reported a
correlation between age-associated loss of methylation
and blood composition, but not with age-associated
increases in methylation [58]. However, our data cannot
disentangle cell-type effects. Other contributing factors
may include developmental processes such as age-related
changes to the progenitor cell pool [75-77], as suggested
previously [28], or age-related shifts in blood cell signaling
and metabolism [78].
We identified 431 CpG sites that changed in the opposite
direction from preterm to term birth compared with birth
to 18 years of age (Figure 2). Previous studies in human
prefrontal cortex illustrate non-linear and directional
changes in DNA methylation [27] and gene expression
[79] during aging, suggesting that such changes are
part of normal development. Our data defining CpG
methylation sites that change direction during gestation
and subsequently during post-natal life may reflect a
distinctive methylation signature in the blood of term
neonates. We speculate that these observations may
reflect cell composition or functional differences in blood
cells that are evidently unique to neonates born at full
term [62,80,81].
We found very similar genomic contexts enriched in
birth DMPs and age DMPs. Both showed over-represen-
tation of rDMRs and under-representation of CGIs and
promoter regions. These results are consistent with findings
from cross-sectional studies in adult mice [82] and humans
[25,74], and with longitudinal studies of early post-natal
life [23,83,84]. Taken together, these data indicate that
similar regions of the genome are preferentially subject to
epigenetic change during the second half of gestation, and
during post-natal life in blood, and that these sites overlap
rDMRs associated with in vitro pluripotency reprogram-
ming. Although our genomic context enrichment data
on differential methylation at 18 years used nominallysignificant methylation differences, our results suggest
that inter-individual differences in methylation are more
likely to occur in regions of the genome not associated
with aging. These findings also suggest that gestation-
related and age-related changes are unlikely to relate to
‘epigenetic noise’ [85]. However, we cannot determine if
these observations reflect inter-individual blood com-
position differences, inter-individual DNA methylation
variation, or associations with preterm birth.
At 18 years of age, most methylation differences identi-
fied in preterm babies are resolved, as evidenced by the lack
of genome-wide significance in differential methylation at
this time point. This is consistent with our conclusion that
developmental changes and cell composition are the main
components of methylation variation associated with birth
DMPs and age DMPs. However, comparing preterm and
term group analysis of birth and 18-year samples identified
109 statistically significant DMPs. Interestingly, eight of
these CpG sites were not significantly differentially
methylated at birth, suggesting that a larger sample size
may indeed detect a long-term epigenetic legacy of pre-
term birth at a single time point. We observed persistently
altered CpG methylation at PCSK9, TRIM71, SLC44A4,
GPC6, and NFYA gene loci and at two intergenic CpG
sites flanking a binding site for the EGR1 transcription
factor. Taken together, these observations raise the possi-
bility that persistent DNA methylation differences reflect
a long-term legacy of preterm birth.
Limitations of the study include confounding factors
related to inter-individual variation in blood composition,
which may restrict power to detect birth DMPs and age
DMPs. Our exploratory study requires replication in a
larger cohort. This is particularly important to confirm the
persistent epigenetic legacy of preterm birth identified in
this report. Use of term-equivalent samples from preterm
subjects would be useful in this context. Furthermore,
statistical methods for deconvoluting mixed cell types [66]
or adjustment for age [86] have not been described in
context of gestation or neonatal development. Therefore,
further studies addressing methylation differences in sorted
cells during gestation, at full-term birth, and later in life
may provide empirical data necessary to account for these
confounders, as suggested previously by Houseman and
colleagues [87].
Conclusions
We report the first analysis of genome-scale methylation
profiling using longitudinally collected archived blood spot
DNA comparing very preterm and term subjects. We
identified preterm birth-associated methylation differences
at birth and demonstrated that these are mostly resolved
by 18 years of age. We also described methylation changes
that show a continual change from mid-gestation to young
adulthood, and those that possibly reverse their direction
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http://genomemedicine.com/content/5/10/96of change. Finally, we found a minority of genomic sites
that show persistent methylation differences between terms
and preterms at both time points. These results suggest
that a significant, long-term legacy of preterm birth might
be observed using a larger sample size. Further work is re-
quired to examine if preterm birth-associated methylation
differences co-vary with long-term health outcomes, early
medical interventions, and/or genetic polymorphisms.Additional files
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tandem EGR1 consensus sites. (A) Methylation data from HM450 probe
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RNA sequencing (RNA-seq) reads and DNA methylation from human
frontal cortex specimens derived from the UCSC browser. Figure S5.
Sequenom analysis of long-term DMP at TINAGL1 3′UTR. (A) Methylation
data from HM450 probe targets (red) and nearest analysable Sequenom
EpiTYPER CpG unit (blue) from a Sequenom amplicon encompassing
the target of probe cg06730678 (red). (B) Partial Sequenom amplicon
sequence annotation displayed with CpGs/CpG units highlighted in
the same colors.
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